FDA
-
-
-
-
-
-
-
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
-
-
-
-
-
-
-
Abeona Therapeutics names Keith Goldan to board of directors
-
-
-
-
-
-
-
Abeona reports progress in ZEVASKYN gene therapy commercial launch
-
-
-
-
-
-
-
Abeona activates new treatment center for RDEB gene therapy in Texas
-
-
-
-
-
-
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
-
-
-
-
-
-
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
329,989 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

